newsfilter
← Latest News
GlobeNewswire·

NextCure Provides Business Update and Reports First Quarter 2026 Financial Results

SIM0505/CDH6 ADC dose optimization initiated in gynecologic cancersSIM0505 Phase 1 dose escalation study data to be presented at ASCO 2026 LNCB74 Phase 1 dose escalation trial update planned in second half of 2026